Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
20.27
-0.73 (-3.48%)
At close: Mar 10, 2025, 4:00 PM
20.50
+0.23 (1.13%)
After-hours: Mar 10, 2025, 4:31 PM EST
Enliven Therapeutics Employees
Enliven Therapeutics had 46 employees as of December 31, 2023.
Employees
46
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,852,478
Market Cap
990.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 46 | - | - |
ELVN News
- 12 days ago - Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 2 months ago - Enliven's Early Data Stands Out From Peers - Seeking Alpha
- 4 months ago - Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update - PRNewsWire
- 4 months ago - Enliven Therapeutics to Present at the Jefferies London Healthcare Conference - PRNewsWire
- 5 months ago - Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia - GlobeNewsWire
- 6 months ago - Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML - GlobeNewsWire
- 10 months ago - Enliven Therapeutics to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 10 months ago - Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - GlobeNewsWire